Tirzepatide, a type-2 diabetes drug has been recommended as a treatment for obesity to help patients 'live longer and healthier lives'
Semaglutide can help a person reduce their weight by more than 10% when used alongside a reduced-calorie deficit diet and increased physical activity.
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
